Omniab Inc Stock Buy Hold or Sell Recommendation
| OABI Stock | USD 3.92 0.07 1.82% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding OmniAb Inc is 'Strong Hold'. The recommendation algorithm takes into account all of OmniAb's available fundamental, technical, and predictive indicators you will find on this site.
Check out OmniAb Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as OmniAb and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards OmniAb Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
OmniAb |
Execute OmniAb Buy or Sell Advice
The OmniAb recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on OmniAb Inc. Macroaxis does not own or have any residual interests in OmniAb Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute OmniAb's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
OmniAb Trading Alerts and Improvement Suggestions
| OmniAb Inc generated a negative expected return over the last 90 days | |
| OmniAb Inc currently holds 25.56 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. OmniAb Inc has a current ratio of 0.56, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about OmniAb's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 34.16 M. Net Loss for the year was (50.62 M) with profit before overhead, payroll, taxes, and interest of 59.08 M. | |
| About 69.0% of OmniAb shares are owned by institutional investors | |
| Latest headline from simplywall.st: OmniAb, Inc. Just Reported And Analysts Have Been Cutting Their Estimates |
OmniAb Returns Distribution Density
The distribution of OmniAb's historical returns is an attempt to chart the uncertainty of OmniAb's future price movements. The chart of the probability distribution of OmniAb daily returns describes the distribution of returns around its average expected value. We use OmniAb Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of OmniAb returns is essential to provide solid investment advice for OmniAb.
| Mean Return | -0.02 | Value At Risk | -4.12 | Potential Upside | 3.59 | Standard Deviation | 2.66 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of OmniAb historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
OmniAb Stock Institutional Investors
| Shares | State Street Corp | 2024-06-30 | 2 M | First Sabrepoint Capital Management Lp | 2024-09-30 | 1.7 M | Villere St Denis J & Co Llc | 2024-09-30 | 1.5 M | Orchard Capital Management, Llc | 2024-06-30 | 1.4 M | Adar1 Capital Management Llc | 2024-09-30 | 1.3 M | Millennium Management Llc | 2024-06-30 | 1 M | Kornitzer Capital Management Inc | 2024-09-30 | 898.8 K | Northern Trust Corp | 2024-09-30 | 837.3 K | Kent Lake Capital Llc | 2024-06-30 | 800 K | Avista Capital Holdings Lp | 2024-09-30 | 15.8 M | Hhg Plc | 2024-06-30 | 7.9 M |
OmniAb Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to OmniAb or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that OmniAb's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a OmniAb stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 1.50 | |
σ | Overall volatility | 2.58 | |
Ir | Information ratio | -0.06 |
OmniAb Volatility Alert
OmniAb Inc exhibits very low volatility with skewness of -0.76 and kurtosis of 1.4. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure OmniAb's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact OmniAb's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.OmniAb Fundamentals Vs Peers
Comparing OmniAb's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze OmniAb's direct or indirect competition across all of the common fundamentals between OmniAb and the related equities. This way, we can detect undervalued stocks with similar characteristics as OmniAb or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of OmniAb's fundamental indicators could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare OmniAb to competition |
| Fundamentals | OmniAb | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Operating Margin | (4.74) % | (5.51) % |
| Current Valuation | 438.83 M | 16.62 B |
| Shares Outstanding | 121.01 M | 571.82 M |
| Shares Owned By Insiders | 5.88 % | 10.09 % |
| Shares Owned By Institutions | 68.98 % | 39.21 % |
| Number Of Shares Shorted | 7.98 M | 4.71 M |
| Price To Book | 1.63 X | 9.51 X |
| Price To Sales | 23.24 X | 11.42 X |
| Revenue | 34.16 M | 9.43 B |
| Gross Profit | 59.08 M | 27.38 B |
| EBITDA | (49.73 M) | 3.9 B |
| Net Income | (50.62 M) | 570.98 M |
| Total Debt | 25.56 M | 5.32 B |
| Debt To Equity | 0.11 % | 48.70 % |
| Current Ratio | 0.57 X | 2.16 X |
| Book Value Per Share | 2.43 X | 1.93 K |
| Cash Flow From Operations | 2.35 M | 971.22 M |
| Short Ratio | 27.84 X | 4.00 X |
| Earnings Per Share | (0.62) X | 3.12 X |
| Target Price | 9.75 | |
| Number Of Employees | 106 | 18.84 K |
| Beta | 0.44 | -0.15 |
| Market Capitalization | 474.37 M | 19.03 B |
| Total Asset | 375.23 M | 29.47 B |
| Retained Earnings | (39.37 M) | 9.33 B |
| Working Capital | 71.78 M | 1.48 B |
| Net Asset | 375.23 M |
Note: Acquisition by Kurt Gustafson of 23254 shares of OmniAb subject to Rule 16b-3 [view details]
OmniAb Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as OmniAb . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About OmniAb Buy or Sell Advice
When is the right time to buy or sell OmniAb Inc? Buying financial instruments such as OmniAb Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having OmniAb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Check out OmniAb Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.